{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:35:45Z","timestamp":1794490545304,"version":"4.9.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T00:00:00Z","timestamp":1484784000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s40268-017-0172-1","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T21:34:30Z","timestamp":1484861670000},"page":"91-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Antithyroid Drug-Induced Agranulocytosis: State of the Art on Diagnosis and Management"],"prefix":"10.1007","volume":"17","author":[{"given":"Nuno","family":"Vicente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00edsa","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Carrilho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,19]]},"reference":[{"issue":"9","key":"172_CR1","doi-asserted-by":"publisher","first-page":"3671","DOI":"10.1210\/jc.2013-1954","volume":"98","author":"V Sundaresh","year":"2013","unstructured":"Sundaresh V, Brito JP, Wang Z, Prokop LJ, Stan MN, Murad MH, et al. Comparative effectiveness of therapies for Graves\u2019 hyperthyroidism: a systematic review and network meta-analysis. J Clin Endocrinol Metab. 2013;98(9):3671\u20137. doi: 10.1210\/jc.2013-1954 .","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"172_CR2","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2165\/00003088-198106060-00001","volume":"6","author":"JP Kampmann","year":"1981","unstructured":"Kampmann JP, Hansen JM. Clinical pharmacokinetics of antithyroid drugs. Clin Pharmacokinet. 1981;6(6):401\u201328.","journal-title":"Clin Pharmacokinet."},{"issue":"2","key":"172_CR3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2125.1980.tb05823.x","volume":"9","author":"GG Skellern","year":"1980","unstructured":"Skellern GG, Knight BI, Low CK, Alexander WD, McLarty DG, Kalk WJ. The pharmacokinetics of methimazole after oral administration of carbimazole and methimazole, in hyperthyroid patients. Br J Clin Pharmacol. 1980;9(2):137\u201343.","journal-title":"Br J Clin Pharmacol."},{"issue":"10","key":"172_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/jcem-11-10-1057","volume":"11","author":"EC Bartels","year":"1951","unstructured":"Bartels EC, Sjogren RW. 1-Methyl-2-mercaptoimidazole: a new active antithyroid agent. J Clin Endocrinol Metab. 1951;11(10):1057\u201362. doi: 10.1210\/jcem-11-10-1057 .","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"172_CR5","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1001\/jama.1952.72930280001009","volume":"149","author":"NW Specht","year":"1952","unstructured":"Specht NW, Boehme EJ. Death due to agranulocytosis induced by methimazole therapy. J Am Med Assoc. 1952;149(11):1010\u20131.","journal-title":"J Am Med Assoc."},{"key":"172_CR6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1182\/asheducation-2012.1.174","volume":"2012","author":"LA Boxer","year":"2012","unstructured":"Boxer LA. How to approach neutropenia. Hematology Am Soc Hematol Educ Program. 2012;2012:174\u201382. doi: 10.1182\/asheducation-2012.1.174 .","journal-title":"Hematology Am Soc Hematol Educ Program."},{"issue":"8","key":"172_CR7","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.ejim.2006.07.012","volume":"17","author":"E Andres","year":"2006","unstructured":"Andres E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. Idiosyncratic drug-induced agranulocytosis: update of an old disorder. Eur J Intern Med. 2006;17(8):529\u201335. doi: 10.1016\/j.ejim.2006.07.012 .","journal-title":"Eur J Intern Med."},{"issue":"3","key":"172_CR8","first-page":"257","volume":"33","author":"C Benichou","year":"1991","unstructured":"Benichou C, Solal Celigny P. Standardization of definitions and criteria for causality assessment of adverse drug reactions. Drug-induced blood cytopenias: report of an international consensus meeting. Nouv Rev Fr Hematol. 1991;33(3):257\u201362.","journal-title":"Nouv Rev Fr Hematol."},{"issue":"1","key":"172_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1053\/lc.1999.v133.a94931","volume":"133","author":"TB Haddy","year":"1999","unstructured":"Haddy TB, Rana SR, Castro O. Benign ethnic neutropenia: what is a normal absolute neutrophil count? J Lab Clin Med. 1999;133(1):15\u201322. doi: 10.1053\/lc.1999.v133.a94931 .","journal-title":"J Lab Clin Med."},{"issue":"12","key":"172_CR10","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1210\/jc.2013-2569","volume":"98","author":"H Nakamura","year":"2013","unstructured":"Nakamura H, Miyauchi A, Miyawaki N, Imagawa J. Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan. J Clin Endocrinol Metab. 2013;98(12):4776\u201383. doi: 10.1210\/jc.2013-2569 .","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"172_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/archinte.159.4.369","volume":"159","author":"MM Klauw van der","year":"1999","unstructured":"van der Klauw MM, Goudsmit R, Halie MR, van\u2019t Veer MB, Herings RM, Wilson JH, et al. A population-based case-cohort study of drug-associated agranulocytosis. Arch Intern Med. 1999;159(4):369\u201374.","journal-title":"Arch Intern Med."},{"issue":"3","key":"172_CR12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archinte.1990.00390150107020","volume":"150","author":"J Tajiri","year":"1990","unstructured":"Tajiri J, Noguchi S, Murakami T, Murakami N. Antithyroid drug-induced agranulocytosis. The usefulness of routine white blood cell count monitoring. Arch Intern Med. 1990;150(3):621\u20134.","journal-title":"Arch Intern Med."},{"key":"172_CR13","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0439","author":"J Yang","year":"2016","unstructured":"Yang J, Zhu YJ, Zhong J, Zhang J, Weng WW, Liu Z, et al. Characteristics of antithyroid drug-induced agranulocytosis in patients with hyperthyroidism: a retrospective analysis of 114 cases in a single institution in China involving 9690 patients referred for radioiodine treatment over 15 years. Thyroid. 2016. doi: 10.1089\/thy.2015.0439 .","journal-title":"Thyroid."},{"key":"172_CR14","doi-asserted-by":"publisher","unstructured":"Johnston A, Uetrecht J. Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis. Expert Opin Drug Metab Toxicol. 2014:1\u201315. doi: 10.1517\/17425255.2015.985649 .","DOI":"10.1517\/17425255.2015.985649"},{"issue":"15","key":"172_CR15","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(79)90692-0","volume":"28","author":"DC Lam","year":"1979","unstructured":"Lam DC, Lindsay RH. Accumulation of 2-[14C]propylthiouracil in human polymorphonuclear leukocytes. Biochem Pharmacol. 1979;28(15):2289\u201396.","journal-title":"Biochem Pharmacol."},{"issue":"8","key":"172_CR16","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.revmed.2016.02.014","volume":"37","author":"E Andres","year":"2016","unstructured":"Andres E, Weitten T, Mourot-Cottet R, Keller O, Zulfiqar AA, Serraj K, et al. Antithyroid agents related agranulocytosis: literature review. Rev Med Interne. 2016;37(8):544\u201350. doi: 10.1016\/j.revmed.2016.02.014 .","journal-title":"Rev Med Interne."},{"issue":"2","key":"172_CR17","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2141.1986.tb04130.x","volume":"64","author":"WE Fibbe","year":"1986","unstructured":"Fibbe WE, Claas FH, Van der Star-Dijkstra W, Schaafsma MR, Meyboom RH, Falkenburg JH. Agranulocytosis induced by propylthiouracil: evidence of a drug dependent antibody reacting with granulocytes, monocytes and haematopoietic progenitor cells. Br J Haematol. 1986;64(2):363\u201373.","journal-title":"Br J Haematol."},{"key":"172_CR18","doi-asserted-by":"publisher","first-page":"7633","DOI":"10.1038\/ncomms8633","volume":"6","author":"PL Chen","year":"2015","unstructured":"Chen PL, Shih SR, Wang PW, Lin YC, Chu CC, Lin JH, et al. Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study. Nat Commun. 2015;6:7633. doi: 10.1038\/ncomms8633 .","journal-title":"Nat Commun."},{"key":"172_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.309","author":"CL Cheung","year":"2015","unstructured":"Cheung CL, Sing CW, Tang CS, Cheng VK, Pirmohamed M, Choi CH, et al. HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis. Clin Pharmacol Ther. 2015. doi: 10.1002\/cpt.309 .","journal-title":"Clin Pharmacol Ther."},{"key":"172_CR20","doi-asserted-by":"publisher","unstructured":"Gonzalez-Galarza FF, Christmas S, Middleton D, Jones AR. Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Res. 2011;39(Database issue):D913\u20139. doi: 10.1093\/nar\/gkq1128 .","DOI":"10.1093\/nar\/gkq1128"},{"issue":"6","key":"172_CR21","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S2213-8587(16)00113-3","volume":"4","author":"P Hallberg","year":"2016","unstructured":"Hallberg P, Eriksson N, Ibanez L, Bondon-Guitton E, Kreutz R, Carvajal A, et al. Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population. Lancet Diabetes Endocrinol. 2016;4(6):507\u201316. doi: 10.1016\/S2213-8587(16)00113-3 .","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"4","key":"172_CR22","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.4158\/EP11339.CR","volume":"18","author":"P Mutharasan","year":"2012","unstructured":"Mutharasan P, Oatis W, Kwaan H, Molitch M. Delayed anithyroid drug-induced agranulocytosis. Endocr Pract. 2012;18(4):e69\u201372. doi: 10.4158\/EP11339.CR .","journal-title":"Endocr Pract."},{"issue":"9","key":"172_CR23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","volume":"146","author":"F Andersohn","year":"2007","unstructured":"Andersohn F, Konzen C, Garbe E. Systematic review: agranulocytosis induced by nonchemotherapy drugs. Ann Intern Med. 2007;146(9):657\u201365.","journal-title":"Ann Intern Med."},{"issue":"5","key":"172_CR24","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1089\/thy.2013.0476","volume":"24","author":"S Kobayashi","year":"2014","unstructured":"Kobayashi S, Noh JY, Mukasa K, Kunii Y, Watanabe N, Matsumoto M, et al. Characteristics of agranulocytosis as an adverse effect of antithyroid drugs in the second or later course of treatment. Thyroid. 2014;24(5):796\u2013801. doi: 10.1089\/thy.2013.0476 .","journal-title":"Thyroid."},{"issue":"8","key":"172_CR25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/qjmed\/92.8.455","volume":"92","author":"WH Sheng","year":"1999","unstructured":"Sheng WH, Hung CC, Chen YC, Fang CT, Hsieh SM, Chang SC, et al. Antithyroid-drug-induced agranulocytosis complicated by life-threatening infections. QJM. 1999;92(8):455\u201361.","journal-title":"QJM."},{"issue":"2","key":"172_CR26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1507\/endocrj.EJ12-0332","volume":"60","author":"J Yang","year":"2013","unstructured":"Yang J, Zhong J, Xiao XH, Zhou LZ, Chen YJ, Liu JH, et al. The relationship between bone marrow characteristics and the clinical prognosis of antithyroid drug-induced agranulocytosis. Endocr J. 2013;60(2):185\u20139.","journal-title":"Endocr J."},{"issue":"8","key":"172_CR27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/qjmed\/94.8.423","volume":"94","author":"E Andr\u00e8s","year":"2001","unstructured":"Andr\u00e8s E, Kurtz JE, Perrin AE, Dufour P, Schlienger JL, Maloisel F. Haematopoietic growth factor in antithyroid drug induced agranulocytosis. Q J Med. 2001;94(8):423\u20138.","journal-title":"Q J Med."},{"issue":"3","key":"172_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1089\/thy.2005.15.292","volume":"15","author":"J Tajiri","year":"2005","unstructured":"Tajiri J, Noguchi S. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy? Thyroid. 2005;15(3):292\u20137. doi: 10.1089\/thy.2005.15.292 .","journal-title":"Thyroid."},{"issue":"1","key":"172_CR29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/thy.1999.9.29","volume":"9","author":"S Fukata","year":"1999","unstructured":"Fukata S, Kuma K, Sugawara M. Granulocyte colony-stimulating factor (G-CSF) does not improve recovery from antithyroid drug-induced agranulocytosis: a prospective study. Thyroid. 1999;9(1):29\u201331.","journal-title":"Thyroid."},{"issue":"3","key":"172_CR30","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1507\/endocrj.52.383","volume":"52","author":"E Andres","year":"2005","unstructured":"Andres E, Maloisel F. Granulocyte-colony stimulating factor (G-CSF) therapy in antithyroid drug-induced agranulocytosis. Endocr J. 2005;52(3):383.","journal-title":"Endocr J."},{"issue":"4","key":"172_CR31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/archinte.1993.00410040073011","volume":"153","author":"J Tajiri","year":"1993","unstructured":"Tajiri J, Noguchi S, Okamura S, Morita M, Tamaru M, Murakami N, et al. Granulocyte colony-stimulating factor treatment of antithyroid drug-induced granulocytopenia. Arch Intern Med. 1993;153(4):509\u201314.","journal-title":"Arch Intern Med."},{"issue":"1","key":"172_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF03344959","volume":"17","author":"M Meyer-Gessner","year":"1994","unstructured":"Meyer-Gessner M, Benker G, Lederbogen S, Olbricht T, Reinwein D. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature. J Endocrinol Invest. 1994;17(1):29\u201336. doi: 10.1007\/BF03344959 .","journal-title":"J Endocrinol Invest."},{"issue":"4","key":"172_CR33","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1159\/000448586","volume":"5","author":"H Nakamura","year":"2016","unstructured":"Nakamura H, Ide A, Kudo T, Nishihara E, Ito M, Miyauchi A. Periodic granulocyte count measuring is useful for detecting asymptomatic agranulocytosis in antithyroid drug-treated patients with graves\u2019 disease. Eur Thyroid J. 2016;5(4):253\u201360. doi: 10.1159\/000448586 .","journal-title":"Eur Thyroid J."},{"issue":"4","key":"172_CR34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1159\/000367990","volume":"3","author":"J Robinson","year":"2014","unstructured":"Robinson J, Richardson M, Hickey J, James A, Pearce SH, Ball SG, et al. Patient knowledge of antithyroid drug-induced agranulocytosis. Eur Thyroid J. 2014;3(4):245\u201351. doi: 10.1159\/000367990 .","journal-title":"Eur Thyroid J."}],"container-title":["Drugs in R&amp;D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-017-0172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-017-0172-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-017-0172-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T08:38:42Z","timestamp":1498379922000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-017-0172-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,19]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["172"],"URL":"https:\/\/doi.org\/10.1007\/s40268-017-0172-1","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,19]]}}}